Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Sitaxentan sodium

EU orphan designation number: EU/3/04/234
Active ingredient: Sitaxentan sodium
Indication: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Sponsor: Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Thelin on 10/08/2006 with the number EU/1/06/353

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/10/2004 Centralised Orphan - Designation EMEA/OD/031/04 (2004)4225 of 21/10/2004
12/08/2005 Centralised Orphan - Transfer of orphan designation EMEA/OD/031/04/T/01 (2005)2653 of 13/07/2005
30/09/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/031/04/T/02 (2010)6801 of 28/09/2010
04/03/2013 Centralised Orphan - Removal of orphan designation from Community Register